Q1 2026 Holdings
Filed 2026-05-15 | 46 holdings | $609.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $52.9M | 735,000 | 8.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $49.9M | 795,547 | 8.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $49.3M | 3,550,000 | 8.1% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $48.6M | 1,945,000 | 8.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $46.5M | 1,550,000 | 7.6% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $33.6M | 523,463 | 5.5% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $32.2M | 5,004,439 | 5.3% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $31.1M | 8,300,000 | 5.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $27.3M | 3,356,700 | 4.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $25.1M | 76,000 | 4.1% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $22.8M | 2,629,971 | 3.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $18.2M | 513,632 | 3.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $18.0M | 770,000 | 2.9% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $15.2M | 86,480 | 2.5% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $13.5M | 539,049 | 2.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $12.7M | 350,000 | 2.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $11.7M | 105,000 | 1.9% |
| Concentra Group Holdings PAR(CON) | COMMON STOCK | 20603L102 | $10.8M | 505,822 | 1.8% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $10.7M | 202,300 | 1.7% |
| Phreesia Inc(PHR) | COM | 71944F106 | $9.2M | 1,100,000 | 1.5% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $8.9M | 2,154,381 | 1.5% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $6.5M | 697,108 | 1.1% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $5.8M | 510,578 | 1.0% |
| Emergent Biosolutions Inc(EBS) | COM | 29089Q105 | $5.3M | 639,118 | 0.9% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $5.0M | 180,000 | 0.8% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $4.8M | 302,399 | 0.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.4M | 175,825 | 0.7% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $3.5M | 27,450 | 0.6% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $2.5M | 79,872 | 0.4% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $2.4M | 683,856 | 0.4% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $2.2M | 241,123 | 0.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $2.1M | 1,667,600 | 0.3% |
| Omeros Corp(OMER) | COM | 682143102 | $1.8M | 174,800 | 0.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $1.8M | 4,000 | 0.3% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $1.8M | 515,754 | 0.3% |
| Adicet BIO Inc(ACET) | COM NEW | 007002207 | $1.7M | 250,244 | 0.3% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $1.7M | 200,000 | 0.3% |
| Coya Therapeutics Inc(COYA) | COMMON STOCK | 22407B108 | $1.7M | 420,360 | 0.3% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.5M | 45,000 | 0.2% |
| Irhythm Holdings Inc(IRTC) | COM | 450056106 | $1.2M | 10,000 | 0.2% |
| Trueblue Inc(TBI) | COM | 89785X101 | $974.0K | 249,107 | 0.2% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $650.4K | 123,409 | 0.1% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $623.3K | 5,000 | 0.1% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $549.4K | 50,400 | 0.1% |
| Rein Therapeutics Inc(RNTX) | COM NEW | 00887A204 | $535.1K | 411,600 | 0.1% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $497.1K | 5,000 | 0.1% |